Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 11/20 | 0.62 |
| ▸ | CFTR | P13569 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.50 |
| ▸ | HPGD | P15428 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2367627 | 0.89 | ALDH1A1 (0.69) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| Trifluoroacetic Acid SCHEMBL29088349 | 0.88 | ALDH1A1 (0.50) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| SCHEMBL8439409 | 0.87 | TSHR (0.46) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| SCHEMBL2709885 | 0.82 | ALDH1A1 (0.66) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| SCHEMBL7461130 | 0.80 | ALDH1A1 (0.69) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| SCHEMBL10743516 | 0.80 | MAPT (0.60) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| SCHEMBL28769543 | 0.80 | ALDH1A1 (0.63) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| SCHEMBL10780992 | 0.79 | HPGD (0.59) | ALDH1A1HSD17B10TSHRKDM4EHPGD | |
| SCHEMBL17671189 | 0.79 | ALDH1A1 (0.72) | ALDH1A1HSD17B10CFTRTSHRKDM4E | |
| SCHEMBL1534012 | 0.79 | ALDH1A1 (0.66) | ALDH1A1HSD17B10CFTRTSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025188678-A9 | ICAM-1 TARGETED CAR CONSTRUCTS AND METHODS OF TREATMENT | AffyImmune Therapeutics Inc. (US) | 2025-11-27 | — | — | WO | claimed |
| EP-4110405-A1 | ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY | MCSAF INSIDE ONOCOLOGY (FR) | 2023-01-04 | — | — | EP | claimed |
| WO-2021064332-A1 | ANTI-CD30-DRUG CONJUGATES AND THEIR USE IN THERAPY | MC SAF (FR) | 2021-04-08 | — | — | WO | claimed |
| EP-4181964-A1 | COMPOUNDS CAPABLE OF BINDING TO PROTEINS AND CONJUGATES OBTAINED FROM THESE COMPOUNDS | Mc SAF (FR) | 2023-05-24 | — | — | EP | disclosed |
| EP-4110405-A1 | ANTI-CD56 ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY | MCSAF INSIDE ONOCOLOGY (FR) | 2023-01-04 | — | — | EP | disclosed |
| WO-2021064332-A1 | ANTI-CD30-DRUG CONJUGATES AND THEIR USE IN THERAPY | MC SAF (FR) | 2021-04-08 | — | — | WO | disclosed |
| WO-2020234541-A1 | ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THERAPY | MC SAF (FR) | 2020-11-26 | — | — | WO | disclosed |
| CN-105026574-B | Cell lines | 米迪缪尼有限公司 | 2019-08-30 | — | — | CN | disclosed |
| US-20120165315-A1 | MEPTAZINOL CARBAMATE PRODRUG SALTS | JOSTENS, INC. | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165315-A1 | MEPTAZINOL CARBAMATE PRODRUG SALTS | MEP1A, MEP1B, CTSZ | ALDH1A1 2429/4885HSD17B10 2340/4885CFTR 3426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.